BK virus-specific T cells for immunotherapy of progressive multifocal leukoencephalopathy: an open-label, single-cohort pilot study
Irene Cortese(National Institutes of Health), Erin Beck(National Institutes of Health), Omar Al‐Louzi(National Institutes of Health), Joan Ohayon(National Institutes of Health), Frances Andrada(National Institutes of Health), Ikesinachi Osuorah(National Institutes of Health), Jenifer Dwyer(National Institutes of Health), Bridgette Jeanne Billioux(National Institutes of Health), Nigar Dargah‐zada(National Institutes of Health), Matthew K. Schindler(National Institutes of Health), Kyle Binder(National Institute of Neurological Disorders and Stroke), Lauren Reoma(National Institutes of Health Clinical Center), Gina Norato(National Institutes of Health Clinical Center), Yoshimi Enose‐Akahata(National Institutes of Health), Bryan Smith(National Institutes of Health), Maria Chiara Monaco(National Institutes of Health), Eugene O. Major(National Institutes of Health), Steven Jacobson(National Institutes of Health), David F. Stroncek(National Institutes of Health), Steven L. Highfill(National Institutes of Health), Sandhya R. Panch(National Institutes of Health), Daniel S. Reich(National Institutes of Health), John Barrett(National Institutes of Health), Avindra Nath(National Institutes of Health), Pawel Muranski(National Heart Lung and Blood Institute)
Cited by 61Open Access